Minerva Neurosciences (NERV) Profit After Tax (2013 - 2026)

Minerva Neurosciences (NERV) has 14 years of Profit After Tax data on file, last reported at -$125.4 million in Q1 2026.

• Quarterly Profit After Tax fell 3241.47% year-over-year to -$125.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$415.1 million (down 6736.21% YoY) and the FY2025 annual result came in at -$293.4 million, down 20492.68% from the prior year.
• Profit After Tax advanced to -$125.4 million in Q1 2026, from -$283.7 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $22.5 million in Q3 2024 to a low of -$283.7 million in Q4 2025.
• A 5-year average of -$28.2 million and a median of -$7.0 million in 2023 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2024 — Profit After Tax soared 387.88% — and 2025, when it plunged 6540.09%.
• Tracing NERV's Profit After Tax over 5 years: stood at -$6.7 million in 2022, then slumped by 34.14% to -$9.0 million in 2023, then surged by 52.65% to -$4.3 million in 2024, then sank by 6540.09% to -$283.7 million in 2025, then jumped by 55.79% to -$125.4 million in 2026.
• The last three Profit After Tax figures came in at -$125.4 million (Q1 2026), -$283.7 million (Q4 2025), and -$2.7 million (Q3 2025), per Business Quant data.